Home Blog Page 182

Blog

Pharma Marketing Blog

Most popular

Pfizer – the Rodney Dangerfield of the Drug Industry

Pharma Guy - January 5, 2006

Trains, Planes, School Vans: Unsafe for Chantix Users

Pharma Guy - May 22, 2008

Brand Extinction Looms

Pharma Guy - August 11, 2006

Risk-First DTC: A Tactic to Overcome Resistance

Pharma Guy - September 18, 2007

Study Shows Addyi is Not “Female Viagra” by Any Stretch of...

Pharma Guy - February 29, 2016

Rozerem: Wall Street Analysts Miss You!

Pharma Guy - October 8, 2007

Can This Work for Pharma? The Continual Quest of Creative Advertisers

Pharma Guy - December 2, 2016

GSK Kills the FDA Beast! Avandia Lives Another Day. Stay Tuned...

Pharma Guy - July 15, 2010

Pharma’s Black Knight Parties On!

Pharma Guy - September 10, 2006

Pfizer DTC Pledge: ED is Litmus Test

Pharma Guy - August 14, 2005

1...181182183...240 Page 182 of 240

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

AI-powered pharmaceutical content generation contrasted with medical, legal, and regulatory review processes, illustrating the personalization bottleneck in pharma content operations.

The Personalization Bottleneck: Why AI Is Outpacing Pharma Operations

June 19, 2026

The Label Expansion Playbook: How Pharma Gives Established Brands a Second...

June 19, 2026

Healthcare professional navigating a digital healthcare ecosystem maze toward a discoverable therapy, illustrating the challenge of healthcare discoverability strategy in modern pharmaceutical marketing.

The Discovery Gap: Why Great Therapies Still Get Lost in the...

June 18, 2026